Cost-utility of a multicomponent intervention for fibromyalgia versus usual care: a pragmatic randomised controlled trial.
J Rehabil Med
; 55: jrm12361, 2023 Dec 19.
Article
en En
| MEDLINE
| ID: mdl-38111994
ABSTRACT
OBJECTIVE:
To perform an economic evaluation on a multicomponent intervention programme for patients with fibromyalgia syndrome compared with usual clinical practice in primary care.DESIGN:
A cost-utility analysis was conducted alongside a pragmatic randomised controlled trial (ClinicalTrials.gov https//clinicaltrials.gov/ct2/show/record/NCT04049006) from a societal perspective, a human capital approach, and a 1-year time horizon. PATIENTS Patients diagnosed with fibromyalgia syndrome from the public health system in south Catalonia, Spain.METHODS:
Crude and adjusted incremental cost- utility ratios were estimated to compare the treatment strategies based on cost estimations (direct medical costs and productivity losses) and quality-adjusted life years. One-way and 2-way deterministic sensitivity analyses were performed.RESULTS:
The final analysed sample comprised 297 individuals, 161 in the intervention group and 136 in the control group. A crude incremental cost-utility ratio of 1,780.75 and an adjusted ratio of 851.67 were obtained, indicating that the programme significantly improved patients' quality of life with a cost-increasing outcome that fell below the cost-effectiveness threshold. The sensitivity analysis confirmed these findings when varying large cost components, and showed dominance when increasing session attendance.CONCLUSION:
The proposed multicomponent intervention programme was cost-effective compared with usual care for fibromyalgia, which supports its addition to standard practice in the regional primary care service.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fibromialgia
/
Terapia Combinada
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Rehabil Med
Asunto de la revista:
REABILITACAO
Año:
2023
Tipo del documento:
Article
Pais de publicación:
Suecia